ROCK inhibitors 2. Improving potency, selectivity and solubility through the application of rationally designed solubilizing groups.

Bioorg Med Chem Lett

Vertex Pharmaceuticals, Incorporated, 50 Northern Avenue, Boston, MA 02210, USA. Electronic address:

Published: August 2018

AI Article Synopsis

  • Solubilizing groups are added to kinase inhibitor drugs to improve their solubility for development, often at sites that don't affect their effectiveness.
  • In this study, researchers incorporated these solubilizing groups into Rho kinase (ROCK) inhibitors.
  • The addition not only increased solubility but also boosted the inhibitors' potency and selectivity against a similar kinase, PKA.

Article Abstract

Solubilizing groups have been frequently appended to kinase inhibitor drug molecules when solubility is insufficient for pharmaceutical development. Such groups are usually located at substitution sites that have minimal impact on target activity. In this report we describe the incorporation of solubilizing groups in a class of Rho kinase (ROCK) inhibitors that not only confer improved solubility, but also enhance target potency and selectivity against a closely related kinase, PKA.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2018.06.043DOI Listing

Publication Analysis

Top Keywords

solubilizing groups
12
rock inhibitors
8
potency selectivity
8
inhibitors improving
4
improving potency
4
selectivity solubility
4
solubility application
4
application rationally
4
rationally designed
4
designed solubilizing
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!